Lenalidomide oral monotherapy in relapsed/refractory small lymphocytic non-Hodgkin’s lymphoma Tumor-specific immunoglobulin (idiotype, Id) can serve as a target for therapeutic vaccination against B ...
The alternative text for this image may have been generated using AI. Figure 2: Hydrolysis rates and plasma stability of conjugates. The alternative text for this image may have been generated using ...
Recent collaboration offers more heterogeneous, stable antibody drug conjugates of synthetic tubulin-binding agents shown to rapidly trigger cancer cell death. Targeted drug delivery remains a ...
Safe and effective drug targeting with ADCs requires careful selection of drug, antibody, and linker. Antibody-drug conjugates (ADCs) are targeted therapies that combine a specific antibody or ...
NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of class leading, clinically validated antibody drug conjugates (ADCs) today announces that it will present three ...
One of the fastest-growing segments of pharmaceuticals, as highlighted at the 2024 J.P. Morgan Healthcare Conference, is the antibody-drug conjugate (ADC) segment. ADCs consist of four main elements: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results